News Archives

SPR Therapeutics Announces First Use of SPRINT extensa Dual-lead Peripheral Nerve Stimulation System to Treat Low Back Pain

September 25, 2018

SPRINT offers a non-opioid, non-ablative and non-surgical low back pain treatment alternative CLEVELAND, Sept. 25, 2018 (GLOBE NEWSWIRE) — SPR Therapeutics, Inc., a leader in neurostimulation …

Category: News

FDA Clears SPR Therapeutics’ Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management

August 16, 2018

SPRINT® is the First and Only Dual Lead Capable PNS Platform Company also provides first look at 12-month durability outcomes following 60-day SPRINT therapy Cleveland, Ohio- August 16, 2018 – SPR …

Category: News

Opioid Addiction Kills Tens of Thousands of Americans Each Year. These 2 Scrappy Startups are Trying to Save Those Lives.

November 9, 2017

Opioid abuse is one of America’s top public health problems. But these companies have new ways to help. Read the full article (PDF)

Category: News

SPR Therapeutics® Secures $25 Million in Series C Financing

September 12, 2017

SPR Therapeutics® Secures $25 Million in Series C Financing Funding will support commercialization of SPRINT® PNS System, a non-opioid neurostimulation pain-relief therapy for chronic and acute …

Category: News

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

SPR Therapeutics Announces First Use of SPRINT extensa Dual-lead Peripheral Nerve Stimulation System to Treat Low Back Pain

FDA Clears SPR Therapeutics’ Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management

Opioid Addiction Kills Tens of Thousands of Americans Each Year. These 2 Scrappy Startups are Trying to Save Those Lives.

SPR Therapeutics® Secures $25 Million in Series C Financing

SPR® Therapeutics Named #1 on Crain’s Cleveland Business Fast 50 list

SPR® Therapeutics Debuts New SPRINT® PNS Data for Low Back, Shoulder, Knee, and Headache at the 23rd Annual ASRA Pain Medicine Meeting

Ben Austin, CFO and COO of SPR® Therapeutics, Named to Crain’s Cleveland Business 40 Under 40 List

SPR Therapeutics Founder and CEO Maria Bennett on managing pain with nerve stimulation, not drugs: Women Who Lead